Severe acute intermittent hypoxia elicits phrenic long-term facilitation by a novel adenosine-dependent mechanism

J Appl Physiol (1985). 2012 May;112(10):1678-88. doi: 10.1152/japplphysiol.00060.2012. Epub 2012 Mar 8.

Abstract

Acute intermittent hypoxia [AIH; 3, 5-min episodes; 35-45 mmHg arterial PO(2) (Pa(O(2)))] elicits serotonin-dependent phrenic long-term facilitation (pLTF), a form of phrenic motor facilitation (pMF) initiated by G(q) protein-coupled metabotropic 5-HT(2) receptors. An alternate pathway to pMF is induced by G(s) protein-coupled metabotropic receptors, including adenosine A(2A) receptors. AIH-induced pLTF is dominated by the serotonin-dependent pathway and is actually restrained via inhibition from the adenosine-dependent pathway. Here, we hypothesized that severe AIH shifts pLTF from a serotonin-dependent to an adenosine-dependent form of pMF. pLTF induced by severe (25-30 mmHg Pa(O(2))) and moderate (45-55 mmHg Pa(O(2))) AIH were compared in anesthetized rats, with and without intrathecal (C4) spinal A(2A) (MSX-3, 130 ng/kg, 12 μl) or 5-HT receptor antagonist (methysergide, 300 μg/kg, 15 μl) injections. During severe, but not moderate AIH, progressive augmentation of the phrenic response during hypoxic episodes was observed. Severe AIH (78% ± 8% 90 min post-AIH, n = 6) elicited greater pLTF vs. moderate AIH (41% ± 12%, n = 8; P < 0.05). MSX-3 (28% ± 6%; n = 6; P < 0.05) attenuated pLTF following severe AIH, but enhanced pLTF following moderate AIH (86% ± 26%; n = 8; P < 0.05). Methysergide abolished pLTF after moderate AIH (12% ± 5%; n = 6; P = 0.035), but had no effect after severe AIH (66 ± 13%; n = 5; P > 0.05). Thus severe AIH shifts pLTF from a serotonin-dependent to an adenosine-dependent mechanism; the adenosinergic pathway inhibits the serotonergic pathway following moderate AIH. Here we demonstrate a novel adenosine-dependent pathway to pLTF following severe AIH. Shifts in the mechanisms of respiratory plasticity provide the ventilatory control system greater flexibility as challenges that differ in severity are confronted.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Disease
  • Adenosine / metabolism*
  • Adenosine A2 Receptor Antagonists / administration & dosage
  • Animals
  • Blood Pressure
  • Carbon Dioxide / blood
  • Disease Models, Animal
  • Hypoxia / metabolism*
  • Hypoxia / physiopathology
  • Injections, Spinal
  • Lung / innervation*
  • Male
  • Neuronal Plasticity* / drug effects
  • Oxygen / blood
  • Phrenic Nerve / drug effects
  • Phrenic Nerve / metabolism*
  • Phrenic Nerve / physiopathology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Adenosine A2A / drug effects
  • Receptor, Adenosine A2A / metabolism*
  • Receptors, Serotonin, 5-HT2 / metabolism
  • Respiration*
  • Serotonin / metabolism
  • Serotonin 5-HT2 Receptor Antagonists / administration & dosage
  • Severity of Illness Index
  • Time Factors

Substances

  • Adenosine A2 Receptor Antagonists
  • Receptor, Adenosine A2A
  • Receptors, Serotonin, 5-HT2
  • Serotonin 5-HT2 Receptor Antagonists
  • Carbon Dioxide
  • Serotonin
  • Adenosine
  • Oxygen